MicroRNA-27b-3p inhibits apoptosis of chondrocyte in rheumatoid arthritis by targeting HIPK2
Source abstract
Abstract
BACKGROUND: Understanding the mechanism of chondrocytes degeneration could provide a new potential therapeutic idea for rheumatoid arthritis (RA) treatment. MicroRNA-27b-3p (miR-27b-3p) has been shown to regulate a variety of cell behaviors in various cell types. However, the role of miR-27b-3p in RA remains unknown. MATERIALS AND METHODS: Expression of miR-27b-3p and HIPK2 in cartilage tissues and chondrocytes was characterized using qRT-PCR and Western blot. MiR-27b-3p was overexpressed or suppressed in chondrocytes to observe the potential role of miR-27b-3p. RESULTS: We found declined miR-27b-3p and elevated HIPK2 in RA tissues and cells using qRT-PCR. Dual-luciferase reporter assay validated HIPK2 is a direct target of miR-27b-3p, confirmed by Western blot results. Pearson correlation presented that there was a significantly negative correlation between miR-27b-3p and HIPK2 mRNA. Overexpression of miR-27b-3p significantly reduced the expression of pro-apoptotic protein c-caspase3 and increased the expression of anti-apoptotic Bcl-2; however, downregulation of miR-27b-3p has a significant effect of inducing apoptosis. Furthermore, overexpression of miR-27b-3p combined with recombinant HIPK2 protein showed the inhibitory effect of miR-27b-3p was abolished by HIPK2. CONCLUSION: We found declined miR-27b-3p and elevated HIPK2 in RA tissues and cells. Further in vitro studies demonstrated that miR-27b might inhibit chondrocyte apoptosis and thus attenuate RA development by directly inhibiting HIPK2 expression.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: MicroRNA in disease regulation · Osteoarthritis Treatment and Mechanisms · Rheumatoid Arthritis Research and Therapies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopedics, Hunan Provincial People’s Hospital
Department of Orthopedics, Xinsha Nianlun Orthopedic Hospital
Department of Orthopedics, Huarong County People’s Hospital
School of Medicine, Hunan Normal University
References (33)
Show source-provided references
1. 10.1016/j.jim.2016.10.00210.1016/j.jim.2016.10.002 ↗
2. 10.1016/j.jaut.2009.12.00910.1016/j.jaut.2009.12.009 ↗
3. 10.1093/rheumatology/kes11310.1093/rheumatology/kes113 ↗
4. 10.1136/annrheumdis-2015-20752410.1136/annrheumdis-2015-207524 ↗
5. 10.1002/1529-0131(200005)43:5<953::AID-ANR1>3.0.CO;2-Q10.1002/1529-0131(200005)43:5<953::AID-ANR1>3.0.CO;2-Q ↗
6. 10.1016/j.intimp.2017.05.03410.1016/j.intimp.2017.05.034 ↗
7. 10.1186/s13075-017-1303-310.1186/s13075-017-1303-3 ↗
8. 10.1007/s12026-011-8247-510.1007/s12026-011-8247-5 ↗
9. 10.1111/j.1749-6632.2009.05121.x10.1111/j.1749-6632.2009.05121.x ↗
10. 10.1186/s13075-016-1085-z10.1186/s13075-016-1085-z ↗
11. 10.1159/00049479310.1159/000494793 ↗
12. 10.1007/s11626-018-0310-210.1007/s11626-018-0310-2 ↗
13. 10.1016/j.gene.2018.11.01410.1016/j.gene.2018.11.014 ↗
14. 10.1371/journal.pone.006068710.1371/journal.pone.0060687 ↗
15. 10.1074/jbc.M109.01261710.1074/jbc.M109.012617 ↗
16. 10.1002/art.2758410.1002/art.27584 ↗
17. 10.1007/s10067-015-3101-010.1007/s10067-015-3101-0 ↗
18. 10.1016/j.bcp.2016.03.01810.1016/j.bcp.2016.03.018 ↗
19. 10.1002/jcb.2620510.1002/jcb.26205 ↗
20. 10.1016/j.autrev.2015.07.00510.1016/j.autrev.2015.07.005 ↗
21. 10.1002/art.2443610.1002/art.24436 ↗
22. 10.1002/1529-0131(200106)44:6<1234::AID-ART213>3.0.CO;2-R10.1002/1529-0131(200106)44:6<1234::AID-ART213>3.0.CO;2-R ↗
23. 10.1016/j.devcel.2006.09.00910.1016/j.devcel.2006.09.009 ↗
24. 10.1136/annrheumdis-2013-20437710.1136/annrheumdis-2013-204377 ↗
25. 10.1002/art.2447510.1002/art.24475 ↗
26. 10.1371/journal.pone.001982710.1371/journal.pone.0019827 ↗
27. 10.1007/s00109-013-1042-010.1007/s00109-013-1042-0 ↗
28. 10.1016/bs.ctdb.2016.10.00210.1016/bs.ctdb.2016.10.002 ↗
29. 10.3892/ijmm.2014.200810.3892/ijmm.2014.2008 ↗
30. 10.1038/ncb71410.1038/ncb714 ↗
31. 10.1038/ncb71510.1038/ncb715 ↗
32. 10.1038/onc.2010.18310.1038/onc.2010.183 ↗
33. 10.18632/oncotarget.2263010.18632/oncotarget.22630 ↗